The MR Neuroimaging Core, new to the ADRC in this competing renewal, serves two basic roles: l) MR imaging is an essential part of the clinical evaluation performed within the Clinical Core but the wealth of information available from the images has not until now been accessible to investigators for systematic review and quantitative analysis. The concept that the radiology report is an adequate summary of the image data is no longer tenable as quantitative morphometry has become technically feasible. Hence the Core provides the highest quality clinical study, systematic archiving of the image data and technological development of software tools for morphometric analyses. 2) MR techniques have evolved in terms of rapidity such that considerably more information than just high resolution anatomy can be obtained without prolongation of the MR examination time. These opportunities have been exploited by investigators elsewhere and the Core makes such tools available to investigators at this institution. These tools include IH spectroscopy with particular reference to quantitative measurement of N- acetyl metabolites such as N-acetyl aspartate, quantitative morphometry and functional MRI. The MR examination performed in vivo contains information that can be considered to be equivalent to the brain bank of the Neuropathology Core. The MR Neuroimaging Core is the repository for these image data and for the development of the tools for quantitative processing. As the MR technology evolves, the MR Neuroimaging Core implements new applications to acquire new information for ADRC investigators. As this is the mandate of the MR Research Program and involves no cost to the MR Neuroimaging Core, the ADRC capitalizes on the institutional investment in neuroimaging for ADRC investigators. Although this Core is closely connected to the Administrative, Clinical and Neuropathology Cores, the three Projects of Drs. Ferrell, Reynolds and Becker and the Pilot Project of Dr. Thulborn as well as other federally funded grants outside the ADRC, the full impact of this Core has yet to be made, given the recent formation of the MR Research Program at UPMC on which it is based.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005133-16S1
Application #
6098025
Study Section
Project Start
1999-08-01
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Jiang, Yun; Sereika, Susan M; Lingler, Jennifer H et al. (2018) Health literacy and its correlates in informal caregivers of adults with memory loss. Geriatr Nurs 39:285-291
Laymon, Charles M; Minhas, Davneet S; Becker, Carl R et al. (2018) Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging. Mol Imaging Biol 20:826-834
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Minhas, Davneet S; Price, Julie C; Laymon, Charles M et al. (2018) Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of A? load. Neuroimage Clin 19:182-189
Mukherjee, Shubhabrata; Mez, Jesse; Trittschuh, Emily H et al. (2018) Genetic data and cognitively defined late-onset Alzheimer's disease subgroups. Mol Psychiatry :
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Hu, Ziheng; Wang, Lirong; Ma, Shifan et al. (2018) Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimers Dement (N Y) 4:542-555
Brainstorm Consortium (see original citation for additional authors) (2018) Analysis of shared heritability in common disorders of the brain. Science 360:

Showing the most recent 10 out of 667 publications